BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/25/2022 11:36:34 AM | Browse: 369 | Download: 850
 |
Received |
|
2022-07-20 09:19 |
 |
Peer-Review Started |
|
2022-07-20 09:22 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-08-08 02:19 |
 |
Revised |
|
2022-10-05 09:55 |
 |
Second Decision |
|
2022-11-17 04:28 |
 |
Accepted by Journal Editor-in-Chief |
|
2022-11-18 02:11 |
 |
Accepted by Executive Editor-in-Chief |
|
2022-11-23 00:03 |
 |
Articles in Press |
|
2022-11-23 00:03 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2022-11-24 10:31 |
 |
Publish the Manuscript Online |
|
2022-11-25 11:36 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cell Biology |
Manuscript Type |
Basic Study |
Article Title |
Tumor necrosis factor-α inhibition restores matrix formation by human adipose-derived stem cells in the late stage of chondrogenic differentiation
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jiang-Tao Wan, Xian-Shuai Qiu, Zhuo-Hang Fu, Yong-Can Huang and Shao-Xiong Min |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Natural Science Foundation of Guangdong Province, China |
2017A030313564 |
Shenzhen High-level Hospital Construction Fund to Peking University Shenzhen Hospital |
|
|
Corresponding Author |
Shao-Xiong Min, PhD, Chief Physician, Department of Spine Surgery, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Futian District, Shenzhen 518036, Guangdong Province, China. msxbear24@163.com |
Key Words |
Adipose-derived mesenchymal stem cells; Human adipose-derived mesenchymal stem cells; Chondrogenic differentiation; Tumor necrosis factor-alpha; Etanercept; Infliximab; Nuclear factor kappa-B |
Core Tip |
Adipose stem cells are important seed cells that are used in cartilage tissue engineering. However, at present, cartilage matrix secretion by adipose-derived stem cells (ADSCs) inevitably decreases during the late stage of induced chondrogenic differentiation in vitro, which seriously limits the further application of ADSCs. Our team found that the level of inflammation in the culture system, mainly the levels of tumor necrosis factor-alpha (TNF-α) and matrix metalloproteinase 3, continuously increased during the chondrogenic differentiation of ADSCs. To address this issue, our team added etanercept or infliximab, which are targeted inhibitors of TNF-α, to the chondrogenic differentiation induction medium and successfully restored matrix formation by human ADSCs in the late stage of chondrogenic differentiation. Further studies found that these effects were achieved by reducing NF-κB pathway activation. |
Publish Date |
2022-11-25 11:36 |
Citation |
Wan JT, Qiu XS, Fu ZH, Huang YC, Min SX. Tumor necrosis factor-α inhibition restores matrix formation by human adipose-derived stem cells in the late stage of chondrogenic differentiation. World J Stem Cells 2022; 14(11): 798-814 |
URL |
https://www.wjgnet.com/1948-0210/full/v14/i11/798.htm |
DOI |
https://dx.doi.org/10.4252/wjsc.v14.i11.798 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345